Thermo Fisher Scientific Expands Its Liquid Biopsy and Immunooncology Portfolio
Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immunooncology.
Read MorePosted by Elaine Sanchez Wilson | Mar 21, 2018 | Culture Media, Pancreatic |
Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immunooncology.
Read MorePosted by Elaine Sanchez Wilson | Mar 12, 2018 | Lung Cancer, Melanoma, Pancreatic, Software, Standards |
Presenting an evaluation of the GeneReader next-generation sequencing (NGS) system, the article assesses the performance of the system in comparison with an alternative NGS technology.
Read MorePosted by Elaine Sanchez Wilson | Mar 7, 2018 | Research |
An expert review from the American Society of Clinical Oncology and the College of American Pathologists has provided an assessment of current evidence about the use of liquid biopsy tests in oncology.
Read MorePosted by Elaine Sanchez Wilson | Mar 1, 2018 | Lung Cancer |
Key medical societies are offering new standards for the molecular testing of lung cancers to guide targeted therapies.
Read MorePosted by Elaine Sanchez Wilson | Feb 6, 2018 | Blood Banking, Controls, Pancreatic, Plates, Software, Swabs, Urinalysis & Toxicology |
This month’s issue features laboratory reagents and consumables from such companies as Audit Microcontrols, Bio-rad Laboratories, and Diasorin Molecular.
Read More